<DOC>
	<DOCNO>NCT00233883</DOCNO>
	<brief_summary>The purpose study evaluate tolerability subcutaneous needle-free injection device use administer Fuzeon , compare standard needle/syringe supply commercial Fuzeon . The anticipated time study treatment &lt; 3 month , target sample size &lt; 100 individual .</brief_summary>
	<brief_title>WAND Study - A Study Evaluate Fuzeon ( Enfuvirtide ) Administered Needle-Free Injection Device Patients With HIV .</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Enfuvirtide</mesh_term>
	<criteria>male female patient , &gt; =18 year age HIV1 infection ; previously treat antiretroviral agent . prior use Fuzeon T1249 ; inability selfinject ; active , untreated opportunistic infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>